Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study

Photodiagnosis and Photodynamic Therapy - Tập 36 - Trang 102523 - 2021
Yilin Yao1,2,3, Linjun Shi1,2,3, Yufeng Wang1,2,3, Xuemin Shen1,4,5, Sai Ye1,2,3, Guoyao Tang1,4,5,2,3, Lan Wu1,2,3
1Department of Oral Mucosal disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
2National Clinical Research Center for Oral Diseases, Shanghai 200011, China
3Shanghai Key Laboratory of Stomatology, Shanghai, 200011, China
4College of Stomatology, Shanghai Jiao Tong University, Shanghai 200011, China
5National Center for Stomatology, Shanghai 200011, China

Tài liệu tham khảo

Kramer, 1978, Definition of leukoplakia and related lesions: an aid to studies on oral precancer, Oral Surg. Oral Med. Oral Pathol., 46, 518, 10.1016/0030-4220(78)90383-3 Chaturvedi, 2020, Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study, J. Natl. Cancer Inst., 112, 1047, 10.1093/jnci/djz238 Chuang, 2018, Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: a prospective cohort study of Taiwanese nationwide oral cancer screening program, Oral Oncol., 87, 58, 10.1016/j.oraloncology.2018.10.021 Lodi, 2016, Interventions for treating oral leukoplakia to prevent oral cancer, Cochrane Database Syst. Rev., 7 Sundberg, 2019, Recurrence rates after surgical removal of oral leukoplakia-a prospective longitudinal multi-centre study, PLoS One, 14, 10.1371/journal.pone.0225682 Holmstrup, 2006, Long-term treatment outcome of oral premalignant lesions, Oral Oncol., 42, 461, 10.1016/j.oraloncology.2005.08.011 Dong, 2019, Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis, Lasers Med. Sci., 34, 209, 10.1007/s10103-018-2674-7 Roodenburg, 1983, Treatment of superficial lesions of the oral-mucosa with the carbon-dioxide laser: a report of 58 cases, with 5 years follow-up, J. Exp Clin. Canc. Res., 2, 283 van der Hem, 2008, CO2 laser evaporation of oral lichen planus, Int. J. Oral Maxillofac. Surg., 37, 630, 10.1016/j.ijom.2008.04.011 Lodi, 2008, Management of potentially malignant disorders: evidence and critique, J. Oral Pathol. Med., 37, 63, 10.1111/j.1600-0714.2007.00575.x de Pauli Paglioni, 2020, Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis, Oral Oncol., 109, 10.1016/j.oraloncology.2020.104850 Roodenburg, 1991, Carbon dioxide laser surgery of oral leukoplakia, Oral Surg. Oral Med. Oral Pathol., 71, 670, 10.1016/0030-4220(91)90271-D van der Hem, 2005, The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up, Oral Oncol., 41, 31, 10.1016/j.oraloncology.2004.06.010 Kwiatkowski, 2018, Photodynamic therapy–mechanisms, photosensitizers and combinations, Biomed. Pharmacother., 106, 1098, 10.1016/j.biopha.2018.07.049 Donohoe, 2019, Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity, Biochim. Biophys. Acta Rev. Cancer, 1872, 10.1016/j.bbcan.2019.07.003 Choi, 2017, Comparative analysis of the effects of CO2 fractional laser and sonophoresis on human skin penetration with 5-aminolevulinic acid, Lasers Med. Sci., 32, 1895, 10.1007/s10103-017-2305-8 Fan, 1996, Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity, Cancer, 78, 1374, 10.1002/(SICI)1097-0142(19961001)78:7<1374::AID-CNCR2>3.0.CO;2-L Grant, 1993, Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity, J. Laryngol. Otol., 107, 1140, 10.1017/S0022215100125496 Huth, 2016, Ablative non-sequential fractional ultrapulsed CO2 laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model, Exp. Dermatol., 25, 997, 10.1111/exd.13068 Yao, 2020, Photodynamic therapy combined with carbon dioxide laser for low-grade vaginal intraepithelial neoplasia: A retrospective analysis, Photodiagn. Photodyn. Ther., 30, 10.1016/j.pdpdt.2020.101731 Choi, 2015, Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial, Br. J. Dermatol., 173, 184, 10.1111/bjd.13542 van der Waal, 2009, Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management, Oral Oncol., 45, 317, 10.1016/j.oraloncology.2008.05.016 Brouns, 2013, Treatment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia, Oral Dis., 19, 212, 10.1111/odi.12007 Sundberg, 2019, Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study, PLoS One, 14, 10.1371/journal.pone.0225682 Warnakulasuriya, 2016, Malignant transformation of oral leukoplakia: a systematic review of observational studies, J. Oral Pathol. Med., 45, 155, 10.1111/jop.12339 Liu, 2012, Oral cancer development in patients with leukoplakia–clinicopathological factors affecting outcome, PLoS One, 7, e34773, 10.1371/journal.pone.0034773 Liu, 2011, Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases, Histopathology, 59, 733, 10.1111/j.1365-2559.2011.03938.x Mogedas-Vegara, 2015, The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients, J. Craniomaxillofac. Surg., 43, 677, 10.1016/j.jcms.2015.03.011 Ishii, 2004, Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features, J. Clin. Laser Med. Surg., 22, 27, 10.1089/104454704773660949 Wong, 2013, A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia, Oral Oncol., 49, 970, 10.1016/j.oraloncology.2013.05.011 Morton, 2019, European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen’s disease and basal cell carcinomas, J. Eur. Acad. Dermatol. Venereol., 33, 2225, 10.1111/jdv.16017 Peng, 2020, Targeted photodynamic therapy of human head and neck squamous cell carcinoma with anti-epidermal growth factor receptor antibody cetuximab and photosensitizer ir700dx in the mouse skin-fold window chamber model, Photochem. Photobiol., 96, 708, 10.1111/php.13267 Pietruska, 2014, Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia, Photodiagn. Photodyn. Ther., 11, 34, 10.1016/j.pdpdt.2013.10.003 Han, 2018, Primary clinical evaluation of photodynamic therapy with oral leukoplakia in Chinese patients, Front. Physiol., 9, 1911, 10.3389/fphys.2018.01911 Wong, 2019, British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018, Br. J. Dermatol., 180, 730, 10.1111/bjd.17309 Vrani, 2019, Short incubation fractional CO2 laser assisted photodynamic therapy vs. conventional photodynamic therapy in field cancerized skin: 12-month follow-up results of a randomized intraindividual comparison study, J. Eur. Acad. Dermatol. Venerol., 33, 79, 10.1111/jdv.15109 Zhang, 2017, Treatment of oral refractory large area mucosal leukoplakia with CO2 laser combined with photodynamic therapy: Case report, Photodiagn. Photodyn. Ther., 20, 193, 10.1016/j.pdpdt.2017.10.006 Yao, 2020, The combination of photodynamic therapy and fractional CO2 laser for oral leukoplakia: case series, Photodiagn. Photodyn. Ther., 29, 10.1016/j.pdpdt.2019.101597 Che, 2020, Therapeutic evaluation of 5-aminolevulinic acid-mediated photodynamic therapy in Bowenoid papulosis, Photodiagn. Photodyn. Ther., 29, 10.1016/j.pdpdt.2019.101635 Metelitsa, 2010, Fractionated laser skin resurfacing treatment complications: a review, Dermatol. Surg., 36, 299, 10.1111/j.1524-4725.2009.01434.x Christensen, 2010, Guidelines for practical use of MAL-PDT in non-melanoma skin cancer, J. Eur. Acad. Dermatol. Venereol., 24, 505, 10.1111/j.1468-3083.2009.03430.x